AI 채팅
Loading data for XTNT — first visit, this takes a few seconds.

Xtant Medical Holdings, Inc.

XTNT · NYSE American · USD

0.32 -0.01 (-3.03%)

종가 기준: Sep 16, 2026, 6:17 PM

시가총액
$46.30M

Xtant Medical Holdings, Inc.(XTNT) 주가, 분석 및 데이터

내재가치

내재 가치 로딩 중…

애널리스트 전망

주가 전망 →

애널리스트 전망 없음

12개월 목표가 · 애널리스트 n/a명

애널리스트 컨센서스: n/a

간격:1D
캔들과 신호 불러오는 중…

재무 실적

재무 정보 보기 →
매출 (ttm)
$109.5M

불러오는 중...

최근 실적

발표치예상 대비전년 대비
매출$23.03Mn/a-34.96%
EPS-$0.03-$0.01-200.00%

다음 실적 발표

장 시작 전입니다.

예상치 · 업그레이드 →

실적 상세 보기 →

지표

매수호가
0.3
순이익 (ttm)
-11.1M
-0.15
-0.08
n/a
-11
P/B (ttm)
1.16
P/S (ttm)
0.42
실적 발표일
Nov 9, 2023
매도호가
0.33
거래량
503,295
평균 거래량 (20일)
1,712,650
시가
0.33
전일 종가
0.33
일중 범위
0.32 - 0.33
52주 범위
0.27 - 0.95
배당
n/a
배당락일
n/a

Xtant Medical Holdings, Inc. 소개

기업 정보 보기 →
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana. Medical Devices · Healthcare

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana.

섹터 Healthcare
IPO 일자 Jul 1, 2010
직원 수 151
상장 거래소 NYSE American
티커 XTNT